Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Clozic (ICI 55897) exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 782.00 | |
5 mg | In stock | $ 1,230.00 | |
10 mg | In stock | $ 1,680.00 | |
25 mg | In stock | $ 2,490.00 | |
50 mg | In stock | $ 3,360.00 | |
100 mg | In stock | $ 4,530.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 1,470.00 |
Description | Clozic (ICI 55897) exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent. |
In vitro | Clozic (>50 μM) dose-dependently decreases the amount of matrix protein synthesized by RHMC cell cultures. Clozic dose-dependently inhibits RHMC cell culture growth. Clozic (500 μM) does not affect Lactate dehydrogenase levels[1]. |
Synonyms | Clobuzarit, ICI 55897 |
Molecular Weight | 304.77 |
Formula | C17H17ClO3 |
CAS No. | 22494-47-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (147.65 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Clozic 22494-47-9 Others ICI-55897 ICI55897 Clobuzarit ICI 55897 inhibitor inhibit